Cambridge Healthtech Institute encourages attendees to gain further exposure by presenting their work in the poster sessions. To secure a poster board and inclusion in the conference materials, your abstract must be submitted, approved and your registration paid in full by 2 October 2015.

Register online, or by phone, fax or mail.  Please indicate that you would like to present a poster.  Once your registration has been fully processed, we will send an email with a unique link and instructions for submitting your abstract using our online abstract submission tool.  Please see below for more information. 

Reasons you should present your research poster at this conference: 

  • Your research will be seen by our international delegation, representing leaders from
    top pharmaceutical, biotech, academic and government institutions
  • Receive €45 off your registration
  • Your poster abstract will be published in our conference materials


 NOTE: Special poster restrictions. 


 1. Posters will be limited to ONE poster per person.  


 2. You must select the ONE TRACK at which you wish to present your poster. Your poster will hang only for the duration of that track.  (Your poster selection must be concurrent with your registration selection, but it does not have to be the same.)   * If necessary, posters may be reassigned to another session based on attendance.   

 3. Special poster size required:   Posters should be portrait (vertical) orientation, ISO paper size A0: (841 mm wide x 1189 mm high) or (33.11 inches wide × 46.81 inches high).  Maximum board dimensions are (1000 mm wide x 1200 mm high) or (39.37 inches wide × 47.24 inches high).  Oversize posters will not fit.


* CHI reserves the right to publish your poster title and abstract in various marketing materials and products. 

Click here for poster instructions and guidelines 


Partial List of 2014 Poster Titles

  • Affimed Therapeutics - EGFRvIII T-Cell TandAbs Are Specific and Highly Potent Drug Candidates for the Treatment of a Variety of Solid Tumors

  • Affimed Therapeutics - A CD19/CD3 Bispecific TandAb, AFM11, Recruits T Cells to Potently and Safely Kill CD19+ Tumor Cells in Pre-Clinical Models

  • Ajinomoto Co., Inc. - Site-Specific Protein Conjugation with Corynex® Expression Technology

  • Ajinomoto Co., Inc. - Corynex®: A Gram-Positive Microbial Protein Secretion System That Delivers Better Results

  • Ajou University - A Bispecific Antibody Based on Heterodimeric Fc Demonstrates Potent Anti-Tumor Efficacy by Targeting Met and VEGFR-2 Simultaneously

  • Ajou University - Neuropilin-1-Specific Fc-Fused Peptide Inhibits Tumor Growth by Suppressing Angiogenesis and Metastasis

  • AptaIT GmbH - Next-Generation Analysis of Deep Sequencing Data: Bringing Light into the Black Box of Phage Display Experiments

  • Arabian Gulf University - A Molecular Approach to Develop gG1 Fc Isoforms with Enhanced Affinity to Immune Cells Surface FcγIIIa Receptor

  • Avacta Group plc - High Throughput Measurements of Thermally Induced Unfolding and Aggregation of Proteins Provides Prediction of Long-Term Stability

  • Azarbaijan Shahid Madani University - A Novel Humanized Single-Chain Variable-Fragment Antibody Against the Tumor Necrosis Factor-Alpha

  • Azarbaijan Shahid Madani University - The Binding Affinity of MicroRNA-4732-5p Wrap53 mRNA

  • BerGenBio AS - Novel Therapeutics for Inhibiting Tumor Epithelial-Mesenchymal Transition (EMT), a Key Driver of Metastasis and a Mechanism of Drug-Resistance

  • Bioaster - Insight into the Protein and Cell Engineering Platform of Bioaster, a Technology Institute Specialized in Infectious Diseases and Microbiology: Focus on Stability and Assembly of Bacteriophage Mediated VLPs

  • Bio-Rad AbD Serotec GmbH - Recombinant Anti-Idiotypic Antibodies for Antibody Drug Development

  • Boehringer Ingelheim RCV GmbH & Co KG - Further Improvement of BI pDNA Manufacturing Platform

  • Bruker UK Ltd. - Novel Workflows for Identification and Profiling of Disulfide Bonds in Biopharmaceuticals

  • Catholic University Leuven - Designing Point Mutations That Increase Expression, Solubility and Aggregation Resistance

  • Centre National de la Recherche Scientifique - Amyloids and Prion HSP 104 Mediated Disaggregation

  • Chemical Computing Group, Inc. - A Uniform Framework for Computer-Aided Biologics Design

  • Chemical Computing Group, Inc. - Fully Automated Protocol Generates Antibody Models with High Accuracy

  • Chiome Bioscience, Inc. - ADLib® System: The Avian Cell-Based Antibody Display System with Human Repertoire

  • Chung-Ang University - Efficient Secretory Expression and Purification of the Sweet-Tasting Protein Brazzein in Kluyveromyces lactis

  • Crescendo Biologics Ltd. - HumabodiesTM - Human Single Domain Antibodies from the Crescendo MouseTM

  • Delenex Therapeutics AG - PENTRA®Bodies: Rapid Discovery of Highly Potent Femto- To Low Picomolar Antibody Fragments

  • Elettra-Sincrotrone Trieste S.C.p.A. - Difficult to Express Proteins: Experience from the PROTEO Protein Production Platform

  • Fairjourney Biologics - Naпve Library of Llama Single Domain Antibodies: An Immunization-Free Source of Specificity and Diversity

  • F-star Biotechnology Ltd. - The Display of Fcab and CH3 Libraries on Yeast and Phage

  • Garvan Institute of Medical Research - Expression of Stabilised Human Antibody Fragments in Bacteria

  • Genedata AG - High-Throughput Screening, Design, Production, and Evaluation of Multi-Specific Antibodies

  • Genedata AG - Scaling Up Design and Production of Non-Antibody Tool Proteins

  • Genedata AG - New Workflow System for the Design and Evaluation of Antibody Drug Conjugates (ADCs)

  • Genedata AG - Software for the Complete Characterization of Biopharmaceutical Molecule

  • GeneFrontier Corporation - PUREfrex® 2.0 - An Advanced Version of Reconstituted Cell-Free Protein Synthesis System

  • GlaxoSmithKline - Isolating Neutralising mAbs to a GPCR Using Adimab's Yeast-Based Platform

  • Glycotope GmbH - Biosuperiors: TrasGEX and CetuGEX - Results from Clinical Phase I Studies

  • HORIBA Scientific - Surface Plasmon Resonance Imaging and Particle Size Analysis Solutions to Explore Biomolecular Interactions

  • HORIBA Scientific - High-Throughput and Label-Free Interaction Analysis Platform for Affinity and Kinetics Screening of Biomolecules

  • Immunocore Ltd. - ImmTACs: Targeting Cancer Cells with High Affinity T-Cell Receptors

  • Institut de Recherche en Cancérologie de Montpellier - Restricted Diversity of Paratope Residues in a Collection of 227 Antibody-Antigen Complexes

  • Instituto de Biologia ExperimentalTecnologica - Construction of Antibody Phage Display Libraries for Cancer Research

  • Instituto de Biologia Experimental Tecnologica - Phage Display as a Tool for Development of Novel Therapeutics for Breast Cancer: Targeting Human Delta-Like Ligand1 Notch1 Ligand

  • Korea Institute of Science and Technology - Genetically-Modified Tomato Aspermy Virus 2b Protein as a Tumor-Targeting siRNA Delivery Carrier

  • Lonza Biologics plc - Assessment of Aggregation and Immunogenicity of Biotherapeutics to Improve Developability

  • MaxCyte, Inc. - Optimization of Pre- and Post-Transfection Parameters for Multi-Gram Level CHO Antibody Production Within Two Weeks

  • MedImmune Ltd. - A Phenotypic Screening Approach to Identify Antibody-Tractable Targets in Pancreatic Cancer

  • MedImmune Ltd. - The Importance of Target Selection for Successful Development of Therapeutic Biologics

  • MedImmune Ltd. - Generation of Potent Mouse Monoclonal Antibodies to Self-Proteins Using T-Cell Epitope "Tags"

  • MedImmune Ltd. - Targeting Fibroblasts in the Tumour Microenvironment

  • MedImmune Ltd. - Identification of Antibodies for the Prevention of Amyloid Oligomer Binding to the Cellular Prion Protein

  • Merck Research Laboratories - Automation of Analytical Assays to Support High Throughput BioProcess Development and Monitoring

  • ModiQuest Research BV - Selection of an Anti-Modified Citrulline Antibody by Phage Display

  • MorphoSys AG - Characterization and Screening of IgG Binding to the Neonatal Fc Receptor

  • NanoTemper Technologies - Prometheus NT.48: Rapid, High Throughput Protein Folding Analysis for Drug Discovery and Formulation Development

  • National Institute of Agrobiological Sciences - HYZEL: A High-Yield Zero-Leakage Expression System in Escherichia coli

  • Novartis Vaccines - An Auto-Assembling Staphylococcus aureus Alpha-Hemolysin as a Vaccine Mimicking Natural Immune Response Against the Toxin

  • NovImmune SA - Differential Co-Engagement of TLR4 and FcγRs Modulates the Potency of NI-0101

  • Novo Nordisk A/S - Optimising a High-Concentration mAb Formulation with Respect to Manufacturability-Related Stress

  • Novozymes Biopharma UK Ltd. - Recombinant Human Serum Albumin as an Excipient for Preventing Protein Aggregates and Particles

  • Novozymes Biopharma UK Ltd. - Evolution or Revolution? - Veltis® Technology Demonstrates Significantly Improved Drug Half-Life Beyond Native Albumin: Proof of Concept Study

  • Osaka University - Secretion of Metagenome-Derived LC-Cutinase with PET Degrading Activity to Extracellular Medium of E. coli Cells

  • Particle Metrix GmbH - Multiparameter Particle Characterization by Particle Tracking Analysis (NTA/PTA)

  • Pasteur Institute of Iran - Tracking Intracellular Mechanisms Involved in Specific Productivity Through Investigating Proteomics Profile of Recombinant CHODG44

  • Polish Academy of Sciences - Comparison of Phage ELISA and RISE Detection Methods for Analysis of Phage Displayed Antibody Fragment

  • Polish Academy of Sciences - Molecular Cloning of Variable Fragments from Monoclonal Anti-H5 HA IgG, Expression in Bacteria and Characterization

  • Promega Corporation - Better Cell‐Based Assays for Anti‐CTLA‐4, Anti‐PD1/PD‐L1, and Bispecific Immunotherapy Drug Studies

  • Randox Life Sciences - Generation of a Bispecific VHH Antibody Fragment to Cardiac Troponin I.

  • RIKEN Center for Sustainable Resource Science - Development of a Hyper-Protein Secretion System via a Tat-Dependent Signal Peptide Using Streptomyces lividans

  • Roche Diagnostics GmbH - Bispecific Antibody Mediated Delivery of Toxins to Tumor Cells

  • Roche Diagnostics GmbH - Deciphering the Stepwise Binding Mode of HRG1β to HER3 by Surface Plasmon Resonance and Interaction Map

  • Roche Diagnostics GmbH - Analysis of Classical and Novel Biotherapeutics with Michrochip Capillary Electrophoresis

  • SEPPIC - Surfactants to Prevent Agglomeration of Big Molecules Used in Injectable Drugs

  • Synthelis - CXCR4 Proteoliposomes Cell Free Expression and SPRi Ligand Binding

  • Tallinn University of Technology - N-Glycosylation Site Occupancy in Human Prostaglandin H Synthases Expressed in Pichia pastoris

  • Technical University of Denmark - Engineering the CHO Cell

  • Technische Universitдt Darmstadt - A Generic Approach to Engineer Antibody pH-Switches Using Combinatorial Histidine Scanning Libraries and Yeast Display

  • Technische Universitдt Darmstadt - C4BP: An Alternative Scaffold to Antibody Drug Conjugates with Improved Target Binding Strength and Cytotoxicity

  • Technische Universitдt Darmstadt - Shark Attack: High Affinity Binding Proteins Derived from Shark vNAR Domains by Stepwise In Vitro Affinity Maturation

  • Tosoh Corporation - Efficient Separation of Therapeutic Antibodies Using FcR-Based Affinity Resin

  • TSI, Inc. - Separation of Proteins and Aggregates by Macroion Mobility Spectrometry

  • UCB Pharma - Biophysical Screening for Selection of Stable Therapeutic Antibodies

  • Universidade da Beira Interior - Membrane-Bound Catechol-O-Methyltransferase Biosynthesis in Pichia pastoris: Optimization of the Induction Phase Using Artificial Neural Networks

  • Universidade Nova de Lisboa - Human Pin1 WWdomain Scaffold Production and Applications

  • Universidade Nova de Lisboa - From Small Synthetic Ligands to Small Protein Scaffolds: Peptidomimetics Targeting Biologics

  • Universidade Nova de Lisboa - A Tailor Made Affinity Pair "Tag-Receptor" for Cancer Biotherapeutics Development

  • University College London - The Use of Carrier Proteins to Enhance the Selective Release of a Microbially Expressed Recombinant Protein

  • University Hospital and University of Basel - Microtubule-Depolymerizing Agents Used in ADCs Induce Anti-Tumor Immunity and Synergize with Immune Checkpoint Blocking Antibodies

  • University Medical Center, Hamburg-Eppendorf - Selection of Nanobodies That Neutralize the Binary Clostridium difficile Toxin CDT

  • University Medical Center, Hamburg-Eppendorf - Generation of CD38-Specific Nanobodies and Nanobody-Fc Fusion Proteins for Diagnosis and Therapy of Hematopoietic Neoplasias

  • University of Applied Sciences and Arts Western Switzerland Valais - Recombinant Production of Venom-Derived Three-Finger Toxin Peptides

  • University of Copenhagen - Difficult to Express Potassium Channels of Medical Interest

  • University of Copenhagen - Saccharomyces cerevisiae-Based Platform for Rapid Production and Evaluation of Eukaryotic Membrane Proteins for Crystallography

  • University of Copenhagen - Immunitrack - A Spin-Out from the University of Copenhagen with a Focus on FcRn and MHC II

  • University of Defence - Cloning, Expression and Purification of Francisella tularensis Immunoreactive Proteins

  • University of Natural Resources and Life Sciences - Characterization of Human Diamine Oxidase Produced in CHO

  • University of Queensland - Construction and Expression of Bispecific Antibodies for Targeted Drug Delivery

  • University of Rome "La Sapienza" - Electro-Gene-Transfer: A Platform for Immunone Library Generation and Chimeric Antibody Expression

  • University of Shizuoka - Development of Shiga Toxin-Specific Hybrid IgA-Tag: Focus on the Purification Process

  • University of Shizuoka - Comparison of the Hybrid IgA Expressed in Plant and Mammalian Cell Systems

  • University of Turku - Screening and Epitope Mapping of Phage Antibodies in a Single Assay

  • University of Wroclaw - Cytotoxic Auristatin-Affibody Conjugates That Target HER2-Positive Cancer Cells

  • Vaccinex, Inc. - Antibody Library Display on a Mammalian Virus: Combining the Advantages of Panning and Cell Sorting in One Technology

  • Vrije Universiteit Brussel - Sortase-Mediated Site-Specific Conjugation of Nanobodies for Use in Molecular Imaging